ロード中...
Malignant pleural effusion as a predictor of the efficacy of anti‐PD‐1 antibody in patients with non‐small cell lung cancer
BACKGROUND: The aim of this study was to evaluate the usefulness of the presence of malignant pleural effusion (MPE) as a negative predictor of anti‐PD‐1 antibody efficacy. METHODS: A retrospective review of patients with advanced or recurrent non‐small cell lung cancer treated with an anti‐PD‐1 ant...
保存先:
| 出版年: | Thorac Cancer |
|---|---|
| 主要な著者: | , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
John Wiley & Sons Australia, Ltd
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6449236/ https://ncbi.nlm.nih.gov/pubmed/30762312 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/1759-7714.13004 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|